Direct-Acting Antiviral Therapy in UK-based African Patients With HCV
Investigators analyzed UK residents with HCV born in Africa to examine the effectiveness of direct-acting antivirals in individuals from lower- or middle-income countries.
Hepatitis
Predictors of Relapse in Patients With Chronic Hepatitis B Who Discontinue Nucleos(t)ide Analogue Therapy
Researchers analyzed data from patients with chronic hepatitis B to identify predictors of relapse in those who discontinued NAs and determined if existing rules for stopping NA therapy can be improved.
Liver Cancer Profile Differs in Black Patients With Hep C
Black patients have better liver function at the time of hepatocellular carcinoma diagnosis along with less early-stage HCC and larger tumors.
High Prevalence of HCV Infection in MSM Regardless of HIV Status
The researchers’ objective was to determine the prevalence of HCV antibodies among MSM with and without HIV, as well as factors associated with HCV infection among MSM.
FDA to Review 3-Antigen Prophylactic Hepatitis B Vaccine
The vaccine candidate consists of the S, pre-S1, and pre-S2 surface antigens of the hepatitis B virus.
Hepatic Steatosis Associated With Lower Risks in Chronic Hepatitis B
This study’s goal was to study the effect of fatty liver on the incidence of cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in patients with chronic hepatitis B.
Kidney Transplant Outcomes Similar With Hep C+ Donors
At 1 year after transplant, kidney allograft function, rejection rates similar regardless of donor hepatitis C status.
Autoimmune Hepatitis Linked to Complications in Pregnant Women
In their presentation at The Liver Meeting, a team of investigators from the University of California, San Francisco sought to assess pregnancy outcomes in women with autoimmune hepatitis.
Controversy: Protecting People Who Use Drugs During COVID-19
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
-
Loading...
-
Loading...
